Filing Details
- Accession Number:
- 0000885590-13-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-18 16:23:06
- Reporting Period:
- 2013-06-14
- Filing Date:
- 2013-06-18
- Accepted Time:
- 2013-06-18 16:23:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1477123 | Mitchell Lloyd Segal | 2150 St. Elzear Blvd. West Laval A8 H7L 4A8 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2013-06-14 | 140 | $85.45 | 21,174 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This number represents the actual price purchased, for all shares, in Canadian Dollars on the Toronto Stock Exchange.
- This number represents common shares purchased and other equity awards that were previously reported in Table 1.